Zibb.com: Amylin Pharmaceuticals Incorporated (Industry News & Blogs)

Amylin Pharmaceuticals to Present at the 18th Annual Credit Suiss...

Thu, 05 Nov 2009 21:15:00 GMT

Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference.

Amylin Pharmaceuticals to Present at the 18th Annual Credit Suiss...

Thu, 05 Nov 2009 16:15:00 GMT

Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the 18th Annual Credit Suisse Healthcare Conference in Phoenix, Arizona on Wednesday, November 11, 2009 at 10:00 a.m. PT / 1:00 p.m. ET. Mark Foletta, senior vice president of finance and chief financial officer at Amylin

Amylin signs weight-loss drug deal with Takeda (AP)

Mon, 02 Nov 2009 20:58:58 GMT

NEW YORK (AP) -- Amylin Pharmaceuticals Inc. says it could potentially receive more than $1 billion from a partnership with Japan's Takeda Pharmaceutical Co. on potential

Amylin Pharmaceuticals, Inc. Says Byetta Gets FDA Approval for Ne...

Mon, 02 Nov 2009 12:00:00 GMT

SAN DIEGO and INDIANAPOLIS, Oct. 30, 2009 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN - News) and Eli Lilly and Company (NYSE: LLY - News) today announced that the U.S.

Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement ...

Sun, 01 Nov 2009 23:30:00 GMT

San Diego, CA – November 1, 2009 and Osaka, Japan – November 2, 2009 – Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Takeda Pharmaceutical Company Limited (TSE: 4502) announced today that they have entered into a worldwide exclusive license, development and commercialization agreement to

Amylin Pharmaceuticals and Biocon Limited Enter a Global Developm...

Thu, 10 Sep 2009 20:15:00 GMT

Amylin and Biocon will collaborate to develop the therapeutic potential of the compound and share development costs. Research will center on Amylin's "phybrid" technology.

Amylin Pharmaceuticals board elects Paulo Costa as chairman

Tue, 25 Aug 2009 05:47:41 GMT

Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory

Amylin Pharmaceuticals elects Costa chairman

Mon, 24 Aug 2009 11:51:15 GMT

NEW YORK (MarketWatch) -- Amylin Pharmaceuticals Inc. said Monday that its board elected Paulo Costa to the post of chairman, effective immediately. Costa previously served as president and chief executive officer of Novartis U.S. Corp. and had worked at Johnson & Johnson for 30 years.

Amylin Pharmaceuticals Elects Costa Chairman

Mon, 24 Aug 2009 11:51:00 GMT

Amylin Pharmaceuticals Elects Costa Chairman

Amylin Pharmaceuticals Announces a New Sales Approach to Better ....

Mon, 04 May 2009 21:12:13 GMT

Changes Will Result in a 35% Sales Force Reduction and Approximately $45 Million Annual GAAP Operating Results Benefit SAN DIEGO, May 4 -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced ...

Amylin Pharms initiated with "neutral"

Tue, 28 Apr 2009 17:31:16 GMT

NEW YORK, April 28 (newratings.com) - Analysts at FTN Midwest initiate coverage of Amylin Pharms (ticker: AMLN) with a "neutral" rating. [more]

Lilly & Amylin: Please Keep It Simple (at CNBC)

Tue, 31 Mar 2009 16:46:00 GMT

Shares of Amylin Pharmaceuticals are rallying on a press release from AMLN and its partners Eli Lilly and Alkermes that their once-a-week version of the injectable diabetes drug Byetta (buy-ate-uh) lowered blood sugar levels more than the pills Januvia from Merck and Actos from Takeda.

Accelrys Announces Support for Microsoft Office SharePoint Server...

Mon, 23 Mar 2009 15:00:00 GMT

Accelrys Announces Support for Microsoft Office SharePoint Server Platform to Expand Reach. - SAN DIEGO, CA--(MARKET WIRE)--Mar 23, 2009 -- Accelrys, Inc. (NasdaqGM:ACCL - News), a leading provider of scientific business intelligence software and services, announced it now supports Microsoft Office

Lilly to post 2008 loss on ImClone costs

Thu, 11 Dec 2008 18:18:14 GMT

NEW YORK (Map, News) - Eli Lilly & Co. said Thursday hefty costs related to its $6.5 billion acquisition of ImClone will force the drugmaker to post a loss for 2008 and significantly lower earnings for 2009.

Amylin, Alkermes Shares Plunge On Possible FDA Delays

Tue, 04 Nov 2008 18:40:38 GMT

San Diego-based Amylin Pharmaceuticals and its partner, Cambridge, MA-based Alkermes, both took a dive in the stock market today after they said they might face

FDA Hurdle Hits Amylin, Alkermes (Update) (at TheStreet.com)

Tue, 04 Nov 2008 17:48:53 GMT

Shares of the drugmakers tumble on news their application for long-acting version of the diabetes drug Byetta don't meet FDA requirements.

Lilly and Amylin Enter Into Supply Agreement for Exenatide Once W...

Tue, 21 Oct 2008 20:05:00 GMT

Lilly and Amylin Enter Into Supply Agreement for Exenatide Once Weekly. - SAN DIEGO and INDIANAPOLIS, Oct. 21 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN - News) and Eli Lilly and Company (NYSE: LLY - News) today announced they have entered into a product supply agreement

Blue Ridge Capital Discloses 5.7% Stake in Millipore

Sun, 19 Oct 2008 12:34:43 GMT

Market Folly submits:According to a 13G filing made with the SEC on October 16th, Blue Ridge Capital ran by John Griffin has disclosed a 5.47% ownership stake in Millipore (MIL). Blue Ridge disclosed that they now own 3,020,000

Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Aler...

Fri, 29 Aug 2008 00:00:00 GMT

News and press releases from the pharmaceutical industry. Comprehensive news coverage for the pharmaceutical sector from PharmiWeb.com

FDA working on new warning label for Amylin, Eli Lilly drug Byett...

Mon, 18 Aug 2008 21:56:00 GMT

WASHINGTON (AP) - Federal regulators are working on a stronger label for a widely used diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co. after deaths were reported with the medication despite earlier government warnings.

Fallout Continues on Roche Bid for Genentech

Mon, 18 Aug 2008 21:30:06 GMT

Despite Genentech's rejection of Roche's $43.7 billion offer last week, coverage of the fallout from thefailedbid

ANALYSIS-ImClone bid sparks biotech rally, maybe premature - Reut...

Fri, 01 Aug 2008 06:05:08 GMT

By Ransdell Pierson NEW YORK (Reuters) - Bristol Myers Squibb Co's bid for longtime cancer-drug partner ImClone Systems Inc on Thursday sparked a biotech rally, but it might

Bristol offers to buy Imclone for $60 a share

Thu, 31 Jul 2008 12:22:06 GMT

NEW YORK (Reuters) - Bristol-Myers Squibb Co has offered to buy ImClone Systems Inc for $60 a share, valuing its biotech partner at $5.2 billion in a deal to strengthen its

Carl Icahn buys Amylin Pharmaceuticals Inc., Motorola Inc, Biogen...

Tue, 20 May 2008 06:03:39 GMT

GuruFocus tracks the stock buys, sells and commentaries of stock investment gurus such as Warren Buffett, George Soros, the best investors.

Earnings highlights: Bank of America, Merck, Mattel, Phillip Morr...

Sat, 26 Apr 2008 09:40:00 GMT

Filed under: Earnings reports, Brinker Intl (EAT), AFLAC Inc (AFL), Bank of America (BAC),